ICICI Bank prices $750 million senior notes at 5.417% coupon

1 min read     Updated on 18 Aug 2026, 11:15 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

ICICI Bank successfully priced USD 750 million in senior unsecured notes at a 5.417% coupon rate. The five-year instrument, issued via the IFSC Banking Unit, will be listed on Indian IFSC exchanges and SGX-ST. Proceeds will fund general corporate purposes.

powered bylight_fuzz_icon
48577508

*this image is generated using AI for illustrative purposes only.

ICICI Bank priced USD 750 million in senior unsecured fixed rate notes through its International Financial Services Centre (IFSC) Banking Unit. The issuance, executed under the bank’s USD 7.5 billion Global Medium Term Note Programme, was completed at 1:39 am IST on August 18, 2026.

The five-year notes carry a coupon rate of 5.417% and are scheduled to mature on August 21, 2031. Interest payments will be made semi-annually on February 21 and August 21 each year until maturity. The securities are unsecured and rank equally with other unsecured obligations of the issuer.

Deal Structure and Listing

The notes were issued as 144A/RegS Registered, Category 2 drawdowns. ICICI Bank plans to list the instruments on multiple international platforms to enhance liquidity and investor access. The proposed listing venues include:

  • Global Securities Market of the India International Exchange IFSC Limited
  • Debt Securities Market of the NSE IFSC Limited
  • SGX-ST (Singapore Exchange Securities Trading)

Use of Proceeds

The net proceeds from the USD 750 million issue will be utilized for general corporate purposes in accordance with relevant regulatory guidelines. The bank disclosed no specific project-linked allocation for this tranche, indicating flexibility in deploying the capital across its balance sheet needs.

What the Numbers Show

The pricing of these notes at a 5.417% coupon reflects the bank’s continued access to international debt markets. By utilizing its IFSC unit for the issuance, ICICI Bank leverages India’s emerging international financial hub structure to tap into offshore liquidity. The decision to list on both Indian IFSC exchanges and Singapore’s SGX-ST suggests a strategy to diversify its investor base across Asian markets while maintaining domestic regulatory compliance.

Historical Stock Returns for ICICI Bank

1 Day5 Days1 Month6 Months1 Year5 Years
-0.47%-1.62%-2.47%+0.08%-1.81%+100.88%

How might the 5.417% coupon rate influence ICICI Bank's future borrowing costs compared to domestic Indian rupee debt instruments?

What impact will the multi-listing strategy on SGX-ST and Indian IFSC exchanges have on the liquidity and trading volume of these notes?

Could this issuance signal a broader trend for other Indian private sector banks to utilize IFSC units for international fundraising?

ICICI Bank schedules investor meets on August 17 and 18

1 min read     Updated on 11 Aug 2026, 09:34 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

ICICI Bank Limited has scheduled investor meetings for August 17 and 18, 2026, complying with SEBI regulations. The bank will attend the Motilal Oswal Global Investor Conference and Axis Capital's India Corporate Day. These in-person group sessions will focus on publicly available information.

powered bylight_fuzz_icon
48009842

*this image is generated using AI for illustrative purposes only.

ICICI Bank Limited ICICI Bank has announced its schedule for investor interactions set for August 17 and 18, 2026. The bank will engage with investors through group meetings at two major financial events in Mumbai: the Motilal Oswal 22nd Annual Global Investor Conference and Axis Capital's India Corporate Day 2026. These sessions provide an opportunity for management to discuss publicly available documents and address investor queries directly.

The disclosure was made in compliance with Regulation 30 read with para A of Schedule III and Regulation 46(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was submitted to both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Limited (NSE) on August 11, 2026. Prashant Mistry, Associate Leadership Team at ICICI Bank, signed the communication.

Investor Meet Schedule

The bank has confirmed participation in the following events:

Event Name Date Type Mode
Motilal Oswal 22nd Annual Global Investor Conference, 2026 August 17, 2026 Group In-person
Axis Capital's India Corporate Day 2026 August 18, 2026 Group In-person

Both interactions are scheduled as in-person group meetings. The bank stated that discussions during these meets will refer strictly to publicly available documents.

Regulatory Compliance

The filing ensures transparency regarding the bank's engagement with the investment community. By adhering to SEBI's listing obligations, ICICI Bank maintains regulatory compliance while facilitating direct access for stakeholders. The notice was addressed to the Listing Departments of both BSE and NSE, located in Mumbai.

Contact Information

For further inquiries regarding these investor relations activities, stakeholders may contact the company secretary at companysecretary@icici.bank.in or reach out via phone at +91-22 4008 8900. The bank's registered office is located in Vadodara, Gujarat, while its corporate headquarters operates from Bandra-Kurla Complex, Mumbai.

Historical Stock Returns for ICICI Bank

1 Day5 Days1 Month6 Months1 Year5 Years
-0.47%-1.62%-2.47%+0.08%-1.81%+100.88%

What specific strategic initiatives or financial targets is ICICI Bank likely to highlight during these August 2026 investor conferences?

How might the bank's performance metrics presented at these events influence short-term stock volatility on the BSE and NSE?

Are there any upcoming regulatory changes in the Indian banking sector that ICICI Bank management may address as part of their compliance discussions?

More News on ICICI Bank

Must Read Next

Stocks

Carysil confirms U.S. quartz surface TRQ does not affect its sink exports 6 mins ago
no imag found
HC bars Zydus Life from launching Novartis-patented Dabrafenib drug 7 mins ago
1 Year Returns:-1.81%